AMGN
31
3
ALLE
30
-5
MCK
77
4
PFE
42
4
XOM
56
2
HIG
74
2
GD
44
3
BAC
66
4
CAT
42
3
EFX
60
3
NRG
62
2
DAL
39
2
DD
46
6
HD
37
-7
CINF
45
2
NOC
47
2
BDX
49
3
HST
27
2
DFS
64
-3
CCL
40
-8
AMGN
31
3
ALLE
30
-5
MCK
77
4
PFE
42
4
XOM
56
2
HIG
74
2
GD
44
3
BAC
66
4
CAT
42
3
EFX
60
3
NRG
62
2
DAL
39
2
DD
46
6
HD
37
-7
CINF
45
2
NOC
47
2
BDX
49
3
HST
27
2
DFS
64
-3
CCL
40
-8
Financhill
Back

Monte Rosa Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

GLUE
Monte Rosa Therapeutics

Last Price:
$5.49
Seasonality Move:
-26.23%
Buy
57

SRPT
Sarepta Therapeutics

Last Price:
$106.83
Seasonality Move:
8.04%
Sell
34
Monte Rosa Therapeutics (GLUE) is a Sell

Is Monte Rosa Therapeutics a Buy, Sell or Hold?

  • The current Monte Rosa Therapeutics [GLUE] share price is $5.50. The Score for GLUE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • GLUE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $106.89. The Score for SRPT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GLUE Stock Price Chart

What is Monte Rosa Therapeutics's stock price today?

  • The Monte Rosa Therapeutics share price today is $5.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLUE is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $106.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

GLUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 35.46 Sell
Chaikin Money Flow: 169381 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.78 - 6.72) Sell
Bollinger Bands (100): (5.48 - 8.62) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.25 Sell
Relative Strength Index (14 RSI): 41.97 Sell
Chaikin Money Flow: 469170 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (106.93 - 115.87) Sell
Bollinger Bands (100): (111.92 - 127.28) Sell

GLUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.07 Sell
20-day SMA: 6.38 Sell
50-day SMA: 6.43 Sell
200-day SMA: 5.9 Sell
8-day EMA: 5.93 Sell
20-day EMA: 6.19 Sell
50-day EMA: 6.52 Sell
200-day EMA: 6.34 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 106.35 Buy
20-day SMA: 109.97 Sell
50-day SMA: 116.57 Sell
200-day SMA: 127.54 Sell
8-day EMA: 106.76 Buy
20-day EMA: 109.7 Sell
50-day EMA: 114.67 Sell
200-day EMA: 122.08 Sell

Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.24 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.86 per share, a decrease next quarter of $0.29 per share, an increase this year of $7.95 per share, and an increase next year of $4.16 per share.

Monte Rosa Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):